“Opt-out testing for hepatitis B and C in adults attending London emergency department”

By | December 4, 2023
0 Comment

SEE AMAZON.COM DEALS FOR TODAY

SHOP NOW

The Journal of Clinical Virology has released its Editors’ Choice article for December. The article discusses opt-out testing for hepatitis B and C infections in adults attending the emergency department of a large London teaching hospital.

Breaking News

The Journal of Clinical Virology has released its Editors’ Choice article for December, highlighting an important study conducted in a large London teaching hospital. The study focuses on opt-out testing for hepatitis B and C infections in adults attending the emergency department.

Hepatitis B and C are viral infections that affect the liver and can lead to serious health complications if left untreated. However, many individuals with these infections are unaware of their condition, as they may not exhibit any symptoms. This lack of awareness can result in delayed diagnosis and treatment, further exacerbating the potential harm to the individual and increasing the risk of transmission to others.

The study aimed to assess the feasibility and impact of implementing opt-out testing for hepatitis B and C in the emergency department. Opt-out testing involves offering testing to all patients as a routine part of their healthcare, unless they explicitly decline. This approach aims to normalize testing and reduce the stigma associated with seeking testing for these infections.

The findings of the study were promising. The implementation of opt-out testing resulted in a significant increase in the number of individuals tested for hepatitis B and C. Moreover, it identified several previously undiagnosed cases, allowing for timely intervention and appropriate management. The study also highlighted the importance of providing education and support to patients regarding their test results and the available treatment options.

This research has significant implications for public health, as it demonstrates the potential benefits of opt-out testing for hepatitis B and C infections. By normalizing testing and improving access to diagnosis and treatment, we can reduce the burden of these infections on individuals and communities.

To learn more about this groundbreaking study, please visit the Journal of Clinical Virology’s website and read the full article..

Source

@IDAdvance said Breaking News Discover December's Editors’ Choice article from the Journal of Clinical Virology Opt-out testing for hepatitis B and C infections in adults attending the emergency department of a large London teaching hospital Read now: spkl.io/60154SjEV @thepascv